We are international
Donate
• videos TEXT SIZE   
webcasts from medical meetings    back

Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma
By Heinz Ludwig, MD
12.17.06
Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma



 related articles